PRESS RELEASE published on 03/11/2026 at 17:45, 8 months ago Inside Information / Other news releases Mauna Kea Technologies announces CLIMB study for Cellvizio® in Pancreatic Cysts selected for ASGE Presidential Plenary Session at DDW 2026, showcasing superior diagnostic accuracy and clinical impact Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE
BRIEF published on 02/10/2026 at 17:50, 9 months 1 day ago Mauna Kea Technologies Secures CE MDR Certification for Cellvizio® Cellvizio Clinical Expansion CE MDR Certification European Commercialization MedTech Regulation
PRESS RELEASE published on 02/10/2026 at 17:45, 9 months 1 day ago Inside Information / Other news releases Mauna Kea Technologies announces CE MDR certification for Cellvizio and probes, marking a key milestone in their European expansion strategy under new regulation Mauna Kea Technologies Cellvizio Regulatory Milestone CE MDR Certification European Expansion Strategy
BRIEF published on 01/21/2026 at 17:50, 9 months 21 days ago Mauna Kea Technologies: 2026 Financial Calendar Unveiled Investor Conferences Financial Calendar Growth Strategies Mauna Kea Technologies Cellvizio
BRIEF published on 11/20/2025 at 17:50, 11 months 21 days ago Mauna Kea's Cellvizio Gen 3 receives approval in China NMPA Approval Chinese Market Mauna Kea Cellvizio Gen 3 Endoscopy
PRESS RELEASE published on 11/20/2025 at 17:45, 11 months 21 days ago Inside Information / Other news releases Mauna Kea Technologies obtains NMPA approval in China for Cellvizio Gen 3 platform, aiming to commercialize independently. Approval valid until November 2030, reinforcing company's assets in China NMPA Approval China Commercialization Mauna Kea Technologies Cellvizio Gen 3 Platform
BRIEF published on 11/14/2025 at 07:50, 11 months 27 days ago Mauna Kea Technologies: Successful Financial Restructuring Capital Increase Restructuring Debt Reduction Mauna Kea Technologies Financial Visibility
PRESS RELEASE published on 11/14/2025 at 07:45, 11 months 27 days ago Inside Information / Other news releases Mauna Kea Technologies successfully completes financial restructuring and €6M capital raise, reducing debt, securing financial visibility, and enhancing equity. Paris and Boston - Nov 14, 2025 Debt Reduction Financial Restructuring Capital Raise Equity Increase Mauna Kea Technologies
BRIEF published on 11/13/2025 at 07:50, 11 months 28 days ago Mauna Kea Technologies Resumes Trading with €5M Capital Raise Financial Strategy Paris Commercial Court Retail Investment Capital Raise Safeguard Plan
PRESS RELEASE published on 11/13/2025 at 07:45, 11 months 28 days ago Inside Information / Other news releases Mauna Kea Technologies exits safeguard proceedings after Paris Commercial Court's approval of the Plan, initiating a minimum €5M capital raise. CEO Sacha Loiseau commits €100,000 to capital increase Paris Commercial Court Capital Raise Mauna Kea Technologies Safeguard Proceedings CEO Sacha Loiseau
Published on 11/11/2026 at 19:31, 43 minutes ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 3 hours 44 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 5 hours 49 minutes ago Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 6 hours 14 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 6 hours 14 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 19:29, 45 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 1 hour 33 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 2 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 6 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 9 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 13 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 1 hour ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
